|
Haleon PLC - Surrey, England-based consumer healthcare company, with brands including Sensodyne and Panadol - Commences the up to £500 million share buyback programme announced in its 2025 preliminary results on February 25. HSBC Bank PLC has agreed to purchase the shares on its behalf. Haleon says the buyback commences immediately and will end no later than August 19, with all repurchased shares being cancelled. Current stock price: 369.80 pence, up 1.0% on Thursday in London 12-month change: down 5.1% Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
